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Corynebacterium parvurn is a gram-
positive anaerobic bacillus with marked
antitumour properties demonstrated under
experimental conditions. Woodruff and
Boak (1966), and Halpern et al. (1966)
were the first to demonstrate that injec-
tion with these organisms enhanced the
survival and decreased the rate of tumour
growth in mice. Since then a number
of authors have confirmed the increased
resistance induced by this agent to a
variety of animal tumours (Smith and
Woodruff, 1968; Mathe, Pouillart and
Lapeyraque, 1969; Currie and Bagshawe,
1970). C. parvuim appears to be most
effective with highly immunogenic tu-
mours such as those induced by chemical
carcinogens (Smith and Scott, 1972) and
may delay or prevent their development
altogether in mice treated with methyl-
cholanthrene (Baum and Baum, 1974).
The mode and route of administration
appear critical, and the effect is easily
overcome by a large tumour burden
(Scott, 1974).
The exact mechanism by which C.
parvurn inhibits tumour growth remains
to be resolved but it is reasonable to
assume that this is related to a non-
specific stimulation of the immune system
of the host. Several biological activities
relating to the effect of C. parvurm on
the immune system have been docu-
mented. There is a nine-fold increase in
the phagocytic activity of the sinusoidal
macrophages of liver and spleen accom-
panied by a 30000 increase in spleen
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weight 8-10 days after a single injection
of these organisms (Halpern et al., 1964).
Surprisingly though, the thymus-depen-
dent functions of mice are depressed,
producing a prolonged survival of homo-
graft, a reduction in delayed hyper-
sensitivity reactions and a reduced graft
versus host response (Scott, 1974).
At the same time C. parvcum boosts
the antibody response to a variety of
antigens in those cases where T cell co-
operation is not required (Howard, Chris-
tie and Scott, 1973). Perhaps as a
result of this effect the treated mice
demonstrate enhanced resistance to a
variety of infections (Adlam, Broughton
anid Scott, 1972). As a result of these
established biological properties it is
widely assumed that C. parvurm mediates
its antitumour properties via the mono-
nuclear phagocytic system (Scott, 1974).
Baum and Fisher (1972) reported an
increased proliferation of macrophage
precursors early in the growth of im-
planted tumours. The relevance of an
increased macrophage population to the
control of cancer was discussed and they
concluded by suggesting that the many
agents that non-specifically augment the
host resistance to cancer might manifest
their activity by mimicking the effect
of circulating tumour products on the
bone marrow. It is the purpose of this
paper to describe experiments designed
to test this hypothesis in relation to the
action of C. parvum.
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ol0( were used throughout. 36 mice were
used for the experiments which were
repeated twice with identical protocols.
The mice were divided up into 4 groups
of 9. Group A were injected with 01 ml
N Salinie i.p. Group B were injected
with 0.1 ml (7 mg/ml) i.p. of the Park
Williams No. 8 toxigenic strain of C1.
diphtheriae, strain No. CN2000 (Wellcome
Research Laboratories). Group C were
injected with 01 ml (7 mg/ml) i.p. of C.
parvurm strain No. CN5888 (Wellcome
Research Laboratories), a strain of the
organism with no antitumour properties.
Group D were injected with 0-1 ml
(7 mg/ml) i.p. of C. parvtum strain No.
CN6134 (Wellcome Research Labora-
tories), a strain of the organism with
established antitumour activity. All
three bacterial preparations were formalin-
fixed washed suspensions free of extra-
cellular products, with 0.01%O thimerosal
as preservative. At 2, 4 and 10 days
after the injection 3 mice from each
group were sacrificed for the study of the
proliferation rate of macrophage pre-
cursors. One femur was dissected out
from each mouse under strict aseptic
conditions. The bone marrow was then
harvested by flushing tissue culture
medium through the medullary cavity.
The tissue culture medium was prepared
in the following proportions for each 11
of stock solution: sterile distilled water-
870 ml, IOx Fischer's medium, with L
Glutamine (Gibco-Biocult) 100 ml, 4.400
NaHCO3 (Wellcome)- 31-5 ml, strep-
tomycin 50 mg and penicillin 500,000 u
in saline 0 5 ml. The marrow cell
suspensions from the 3 femurs in each
group were then pooled. An aliquot of
the pooled marrow cell suspension was
counted and based on this count the
suspension was diluted further with the
same medium so that each 0 3 ml con-
tained 106 cells. 0o3 ml of the suspension
was then added to a dilute agar solution
containing horse serum and conditioned
medium (a source of colony stimulating
factor) making up 10 ml of a viscous
culture medium as followrs: tissue culture
medium 5 0 ml, horse serum (Gibco-
Biocult) 2-5 ml, conditioned medium-
15 ml, 5% molten Agar solution (Difco)-
0 7 ml, marrow cell suspension-106 cells
in 0 3 ml. Conditioned medium as a
source of colony stimulating factor was
prepared by collecting the supernatant
from a monolayer culture of mouse
embryo cells prepared according to the
method used at the Paterson Laboratories,
University of Manchester. The resulting
mixture was then added to a series of
10 tissue culture dishes (Nunclon Delta
30 mm). Thus each dish contained 105
nucleated marrow cells suspended in 1 ml
of a semi-solid medium. These dishes
were then incubated for a week at a
temperature of 37°C in 100% humidity
and an atmosphere containing 500 CO2
in air, in sealed boxes. After this period
discrete colonies of macrophages could
easily be identified under low power
microscopy. It was possible to check
the identity of the cells by harvesting
them with a Pasteur pipette and staining
with 1% Toluidine Blue. Culture periods
of less than 5 days produce variable
percentages of granulocyte colonies, but
at the time the plates were counted
virtually all the colonies were composed
of macrophages (Bradley and Metcalf,
1966). Identification marks on the plates
were replaced by a code so that colony
counts were objectively obtained. Only
groups of 50 cells or more arranged in a
colony were counted. Clusters of cells
were not recorded nor was any attempt
to score the number of cells per colony.
However, a statement regarding the
colony size in general was recorded on
each occasion. Although not an integral
part of the experiment, the spleen size
was noted when the mice were sacrificed.
The results were expressed as macro-
phage colonies per plate and the mean
and standard deviation for each experi-
mental group at the various intervals
after inoculation are shown in the Table.
The counts from the two experiments
were pooled so that each result refers to
20 observations. Statistical analysis was
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TABLE. Macrophage Colonies per Plate
(mean ± s.d.) in Semi-solid Agar with
Conditioned Medium (C(SF)
A
B
c
D
Day 2
,51±13
140±48
141 ±50
227 4 55
Statistical comparisonIs
AvD
B v D
C v D
A v B
A v C
*
*
*
*
*
Day 4
45±41
58 ± 38
166±38
*
*
*
NS
NS
Day 10
29±9
50±29
61 ±29
198 ± 75
*
*
NS
105 nucleatedt rnarrow cells perI (lish, from mice
pretreated by injection with (A) saline, (B) C.
cdiphtheriae, (C) iinactive C. p"rvurn, (D) active C.
parvuin.
* < 0.001.
NS: Not significanit.
carried out using Student's t test in-
corporated into a Sumlock Compucorp
340 Statistician. The colonies from the
mice treated with the active C. parvumn
were much larger than those from all
the other experimental groups on each
day of the experiment: so much so that
they usually could be seen by the naked
eye. At 10 days the spleens of the
mice treated with the active C. parvum
were greatly enlarged, with the expected
300%0 increase in wet weight. By con-
trast, the spleens from the other groups
of mice showed only a slight increase
in size in comparison with untreated
mice. An example of the spleens taken
from each of 3 mice in all 4 experimental
groups 10 days after inoculation is shown
in the Fig.
The results demonstrate that a single
i.p. inoculation of C. parvum (of a strain
wvith established antitumour properties)
produces a highly significant increase in
the proliferation of macrophage precursors
which is maximal at 48 h and persists
for at least 10 days. The increase in
the number of proliferating cells was
accompanied by an increased rate of
proliferation as judged by the size of
macrophage colonies. This phenomenon
was associated with massive splenomegaly
apparent at 10 days. In contrast, the
two groups of bacterial controls (C.
diphtheriae and inactive C. parvurm) only
demonstrated a significant increase in
macrophage colonies at 48 h compared
with the saline controls, but this increase
was significantly less than the active C.
parvumn.
The role of the macrophage in the
host response to cancer has been repeat-
edly emphasized but there is a tendency
in many quarters to downgrade the
importance of this cell in relation to the
T lymphocyte in most reviews on tumour
immunology. However, the macrophage
by its versatility must be considered
important in the host response. The
mature macrophage can take up and
process antigen and in so doing activate
the lymphocyte (Askonas and Rhodes,
1965). The macrophage is also important
as an effector cell, killing target tumour
cells by surface contact (Keller and Jones,
1971). In addition there is evidence
that the macrophage plays a role in
controlling the development of enhance-
ment phenomena (Haughton, 1971). It
is readily apparent therefore why an
increase in the population of macrophages
would be beneficial to the host and
incidentally would explain many of the
biological properties of C. parvumn already
described. In addition to the quantita-
tive response the cells produced may
be qualitatively different, demonstrating
many of the features of macrophages
activated by other agents (Scott, 1974).
Additional evidence that implicates
the monocyte/macrophage precursor as
the target cell for the effect of C. parvurm
comes from the study of the effects of
irradiation. Whole body irradiation of
mice shortly before C. parvum injection,
prevents the development of resistance
to tumour challenge, whilst irradiation
after treatment fails to abrogate the anti-
tumour effect (Milas et al., 1974). This
would suggest that the relevant cell
arose from radiosensitive (rapidly divid-
ing) precursors, but the mature cell was
radioresistant. These are precisely the
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FIG.-Spleens of groups of mice removed 10 days after i.p. injections of: (A) saline, (B) C. diph- theriae, (C) inactive C. parvum and (D) active C. parvum.
characteristics of the monocyte/macro-
phage family of cells (Baum, 1974).
This is not the first description of the
action of C. parvum on macrophage
precursors. Wolmark and Fisher (1974)
showed that C. parvum could stimulate
colony production in tumour-bearing
mice after the initial effect of the tumour
on the bone marrow had waned. More
recently, Dimitrov et al. (1975) reported
a similar effect in non-tumour-bearing
mice but suggested that two i.p. injections
were necessary and the effect was not
seen until 5 days after inoculation. Un-
fortunately, both studies failed to use
adequate controls and the effect described
could have been unrelated to the anti-
tumour property of C. parvum, merely reflecting a response common to all
bacterial infections. The experiments re-
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ported in this paper strongly suggest
that the bone marrow stimulation may
be the key to the unique properties of
the strain of C. parvum with antitumour
effect, as this effect was not demonstrated
by closely related bacteria not possessing
antitumour activity.
Assuming that such is the case, it
becomes worthwhile to explore this phe-
nomenon in depth. The most effective
antitumour regime might be that com-
bination of dose and time interval which
gives the most prolonged and most
potent stimulation to the bone marrow.
In addition, the active component of C.
parvum could be detected by sub-frac-
tionation of the bacterium and re-testing
the resulting fractions in this system.
Finally, and of perhaps key importance
to the planning of therapy for human
malignancies, it might be possible to
determine the msost effective combination
of C. parvum and cytotoxic drugs so
that the two agents might work syner-
gistically. Such a combination has al-
ready been demonstrated to be effective
against both animal and human tumours
(Currie and Bagshawe, 1970; Fisher et
al., 1975; Israel and Edelstein, 1974).
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